Painful peripheral neuropathy: Diagnosis and assessment

CONTINUUM Lifelong Learning in Neurology

Volumn 15, Issue 5, 2009, Pages 13-29

  Freeman, Roy L ^a  

^a XTL Biopharmaceutical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; AMIODARONE; ARSENIC; BORTEZOMIB; CARBOPLATIN; CISPLATIN; DAPSONE; DIDANOSINE; DOCETAXEL; ISONIAZID; MERCURY; METRONIDAZOLE; NEVIRAPINE; OXALIPLATIN; PACLITAXEL; PERHEXILINE; STAVUDINE; SURAMIN; THALIDOMIDE; THALLIUM; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALCOHOLISM; AMYLOID NEUROPATHY; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIABETIC NEUROPATHY; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; EVOKED RESPONSE; FABRY DISEASE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IDIOPATHIC SMALL FIBER NEUROPATHY; IMPAIRED GLUCOSE TOLERANCE; LABORATORY DIAGNOSIS; LASER DOPPLER FLOWMETRY; MALE; MYELINATED NERVE; NERVE CONDUCTION; NEUROPATHIC PAIN; NEUROPATHY; NEUROTOXICITY; NONMYELINATED NERVE; PAIN ASSESSMENT; PATHOGENESIS; PERIPHERAL NEUROPATHY; QUESTIONNAIRE; RATING SCALE; SENSORY SYSTEM EXAMINATION; SKIN BIOPSY; TUBERCULOSIS; VASCULITIS;

EID: 78650721503     PISSN: 10802371     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.CON.0000348852.20265.fe     Document Type: Article

References (65)

1. Adams D. Hereditary and acquired amyloid neuropathies. J Neurol 2001;248(8):647-657.
2. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62(7):1057-1062.
3. Andrade C. A peculiar form of peripheral neuropathy: Familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75(3):408-427.
4. Archer AG, Watkins PJ, Thomas PK, et al. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 1983;46(6):491-499.
5. Baron R. Peripheral neuropathic pain: From mechanisms to symptoms. Clin J Pain 2000;16(2 suppl):12-20.
6. Bennett M. The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs. Pain 2001;92(1-2):147-157.
7. Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain 2007;127(3):199-203.
8. Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004;108(3):248-257.
9. Brady RO. Fabry disease. In: Dyck PJ, Thomas PK, Griffin JW, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1993:1169-1178.
10. Brannagan TH 3rd, Hays AP, Chin SS, et al. Small-fiber neuropathy/neuronopathy associated with celiac disease: Skin biopsy findings. Arch Neurol 2005;62(10):1574-1578.
11. Cable WJ, Kolodny EH, Adams RD. Fabry disease: Impaired autonomic function. Neurology 1982;32(5):498-502.
12. Caravati CM. Insulin neuritis: A case report. Va Med Monthly 1933;59:745-746.
13. Chai J, Herrmann DN, Stanton M, et al. Painful small-fiber neuropathy in Sjogren syndrome. Neurology 2005;65(6):925-927.
14. Chin RL, Sander HW, Brannagan TH, et al. Celiac neuropathy. Neurology 2003;60(10):1581-1585.
15. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: A maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009;32:1-32.
16. Cross AH, Golumbek PT. Neurologic manifestations of celiac disease: Proven, or just a gut feeling? Neurology 2003;60(10):1566-1568.
17. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29(7):1518-1522.
18. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113(1-2):9-19.
19. England JD, Gronseth GS, Franklin G, et al; American Academy of Neurology. Practice parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009;72(2):177-184.
20. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337(13):898-909.
21. Falk RH, Skinner M. The systemic amyloidoses: An overview. Adv Intern Med 2000; 45:107-137.
22. Franklin GM, Shetterly SM, Cohen JA, et al. Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1994;17(10):1172-1177.
23. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology 1997;48(2):332-338.
24. Gibbons CH, Griffin JW, Polydefkis M, et al. The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology 2006;66(2):256-258.
25. Gibbons CH, Illigens BM, Centi J, Freeman R. QDIRT: Quantitative direct and indirect test of sudomotor function. Neurology 2008;70(24):2299-2304.
26. Gonzalez-Duarte A, Robinson-Papp J, Simpson DM. Diagnosis and management of HIV-associated neuropathy. Neurol Clin 2008;26(3):821-832, x.
27. Gorson KC, Herrmann DN, Thiagarajan R, et al. Non-length dependent small fibre neuropathy/ganglionopathy. J Neurol Neurosurg Psychiatry 2008;79(2):163-169.
28. Gorson KC, Ropper AH. Idiopathic distal small fiber neuropathy. Acta Neurol Scand 1995;92(5):376-382.
29. Hadjivassiliou M, Grünewald RA, Davies-Jones GA. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry 2002;72(5):560-563.
30. Hoitsma E, Marziniak M, Faber CG, et al. Small fibre neuropathy in sarcoidosis. Lancet 2002;359(9323):2085-2086.
31. Holland NR, Crawford TO, Hauer P, et al. Small-fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases. Ann Neurol 1998;44(1):47-59.
32. Hughes RA, Umapathi T, Gray IA, et al. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 2004;127(pt 8):1723-1730.
33. Kennedy WR, Sakuta M, Sutherland D, Goetz FC. Quantitation of the sweating deficiency in diabetes mellitus. Ann Neurol 1984;15(5):482-488.
34. Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. Clin J Pain 2003;19(5):306-314.
35. Kyle RA, Dyck PJ. Amyloidosis and neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1993:1294-1309.
36. Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997;336(17):1202-1207.
37. Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002;26(2):173-188.
38. Lacomis D, Giuliani MJ, Steen V, Powell HC. Small fiber neuropathy and vasculitis. Arthritis Rheum 1997;40(6):1173-1177.
39. Lauria G, Devigili G. Skin biopsy as a diagnostic tool in peripheral neuropathy. Nat Clin Pract Neurol 2007;3(10):546-557.
40. Llewelyn JG, Thomas PK, Fonseca V, et al. Acute painful diabetic neuropathy precipitated by strict glycemic control. Acta Neuropathol 1986;72(2):157-163.
41. Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve 2006;34(1):57-61.
42. Mori K, Iijima M, Sugiura M, et al. Sjogren's syndrome associated painful sensory neuropathy without sensory ataxia [published erratum appears in J Neurol Neurosurg Psychiatry 2003;74(10):1447]. J Neurol Neurosurg Psychiatry 2003;74(9):1320-1322.
43. Novak V, Freimer ML, Kissel JT, et al. Autonomic impairment in painful neuropathy. Neurology 2001;56(7):861-868.
44. Otto M, Bak S, Bach FW, et al. Pain phenomena and possible mechanisms in patients with painful polyneuropathy. Pain 2003;101(1-2):187-192.
45. Periquet MI, Novak V, Collins MP, et al. Painful sensory neuropathy: Prospective evaluation using skin biopsy [see comments]. Neurology 1999;53(8):1641-1647.
46. Planté -Bordeneuve V, Ferreira A, Lalu T, et al. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 2007;69(7):693-698.
47. Rajkumar SV, Gertz MA, Kyle RA. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med 1998;104(3):232-237.
48. Schiffmann R, Hauer P, Freeman B, et al. Enzyme replacement therapy and intraepidermal innervation density in Fabry disease. Muscle Nerve 2006;34(1):53-56.
49. Schifitto G, McDermott MP, McArthur JC, et al. Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology 2005;64(5):842-848.
50. Scholz J, Mannion RJ, Hord DE, et al. A novel tool for the assessment of pain: Validation in low back pain. PLoS Med 2009;6(4):e1000047.
51. Scott LJ, Griffin JW, Luciano C, et al. Quantitative analysis of epidermal innervation in Fabry disease. Neurology 1999;52(6):1249-1254.
52. Simmons Z, Blaivas M, Aguilera AJ, et al. Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis. J Neurol Sci 1993;120(1):60-63.
53. Simpson DM, Kitch D, Evans SR, et al. HIV neuropathy natural history cohort study: Assessment measures and risk factors. Neurology 2006;66(11):1679-1687.
54. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001;24(8): 1448-1453.
55. Skinner M, Anderson J, Simms R, et al. Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 1996;100(3):290-298.
56. Steel JM, Young RJ, Lloyd GG, Clarke BF. Clinically apparent eating disorders in young diabetic women: Associations with painful neuropathy and other complications. Br Med J (Clin Res Ed) 1987;294(6576):859-862.
57. Stewart JD, Low PA, Fealey RD. Distal small fiber neuropathy: Results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve 1992;15(6):661-665.
58. Sumner CJ, Sheth S, Griffin JW, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003;60(1):108-111.
59. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM Complications Study. Diabetologia 1996;39(11):1377-1384.
60. Wang AK, Fealey RD, Gehrking TL, Low PA. Patterns of neuropathy and autonomic failure in patients with amyloidosis. Mayo Clin Proc 2008;83(11):1226-1230.
61. Weingarten TN, Watson JC, Hooten WM, et al. Validation of the S-LANSS in the community setting. Pain 2007;132(1-2):189-194.
62. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-1053.
63. Wu EQ, Borton J, Said G, et al. Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France. Curr Med Res Opin 2007;23(9):2035-2042.
64. Yarnitsky D. Quantitative sensory testing [see comments]. Muscle Nerve 1997;20(2):198-204.
65. Ziegler D, Rathmann W, Dickhaus T, et al. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: The MONICA/KORA Augsburg Surveys S2 and S3. Pain Med 2009;10(2):393-400.